As it relates to the CRISPR tool that we discussed, as it relates to gene editing, in particular for genetic disorders like Sickle cell anemia, I am definitely a proponent of these type of efforts.
Considering how problematic Sickle cell is and how many people suffer from it, the potential rewards out weigh the risk.
Compared to other medical procedures, this one is relatively non-invasive.
We are putting cells of various kinds almost everyday through our diets, so this type of cell-transfer therapy feels like common sense to me.
No comments:
Post a Comment